Forte Historical Cash Flow
| FBRX Stock | USD 21.71 1.92 9.70% |
Analysis of Forte Biosciences cash flow over time is an excellent tool to project Forte Biosciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 83.6 K or Total Cash From Financing Activities of 25.6 M as it is a great indicator of Forte Biosciences ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Forte Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Forte Biosciences is a good buy for the upcoming year.
Forte |
About Forte Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Forte balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Forte's non-liquid assets can be easily converted into cash.
Forte Biosciences Cash Flow Chart
Add Fundamental
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Forte Biosciences financial statement analysis. It represents the amount of money remaining after all of Forte Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Forte Biosciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Forte Biosciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.At this time, Forte Biosciences' Total Cashflows From Investing Activities is fairly stable compared to the past year. Total Cash From Financing Activities is likely to rise to about 25.6 M in 2024, despite the fact that Sale Purchase Of Stock is likely to grow to (51.30).
| 2023 | 2024 (projected) | Net Borrowings | 567.1K | 504.1K | Stock Based Compensation | 3.3M | 2.7M |
Forte Biosciences cash flow statement Correlations
Click cells to compare fundamentals
Forte Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Forte Biosciences cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 89.1M | 28.9M | 8.2M | (60.0) | (54.0) | (51.3) | |
| Change In Cash | 1.9M | 51.8M | (16.7M) | (944K) | (4.0M) | (3.8M) | |
| Free Cash Flow | (2.9M) | (18.4M) | (16.7M) | (8.2M) | (28.8M) | (30.2M) | |
| Change In Working Capital | 1.3M | (3.8M) | 720K | 1.7M | (392K) | (372.4K) | |
| Other Cashflows From Financing Activities | 14.0M | 4.9M | (32K) | (44K) | 12K | (46.2K) | |
| Depreciation | 11.0K | 54K | 36K | 0.0 | 9K | 8.6K | |
| Other Non Cash Items | (918K) | 30.9M | 61K | 3.8M | (131K) | (124.5K) | |
| Capital Expenditures | 2.0M | 161.6K | 0.0 | 61K | 88K | 83.6K | |
| Total Cash From Operating Activities | (2.8M) | (18.4M) | (16.7M) | (8.2M) | (28.7M) | (30.1M) | |
| Net Income | (4.1M) | (46.5M) | (21.7M) | (13.9M) | (31.5M) | (33.0M) | |
| Total Cash From Financing Activities | 4.9M | 66.7M | (44K) | 7.2M | 24.7M | 25.6M | |
| End Period Cash Flow | 6.9M | 58.8M | 42.0M | 41.1M | 37.1M | 33.3M | |
| Begin Period Cash Flow | 5.0M | 6.9M | 58.8M | 42.0M | 41.1M | 28.0M | |
| Stock Based Compensation | 35.7K | 956K | 4.2M | 4.0M | 3.3M | 2.7M | |
| Change To Liabilities | 976K | (369K) | (294K) | 207K | 186.3K | 195.6K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Forte Stock Analysis
When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.